Sign In
Buy AQSZF
$0.0026
+0 (+0%)
At Close: Jul 31, 2026
Aequus Pharmaceuticals says it will maintain commercial relationship with Sandoz into 2022
10:13am, Wednesday, 09'th Jun 2021
Aequus Pharmaceuticals Inc (CVE:AQS) (OTCQB:AQSZF) (FRA:AEQ) will maintain its current commercial relationship pertaining to the Vistitan glaucoma drug, with Sandoz into 2022. As a specialty pharm
Aequus Pharmaceuticals first quarter results show good progress in spite of the coronavirus pandemic
08:03am, Monday, 31'st May 2021
Aequus Pharmaceuticals Inc. (CVE:AQS) (OTCQB:AQSZF) has reported its financial results for the first quarter ended March 31, 2021, showing good progress in spite of the coronavirus (COVID-19) pandemi
Aequus Provides General Update and First Quarter 2021 Financial Highlights
05:00am, Monday, 31'st May 2021
VANCOUVER, British Columbia, May 31, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focu
Aequus Pharmaceuticals bringing diverse pipeline of new drugs to the Canadian market
10:22am, Sunday, 30'th May 2021
Focused on developing and commercializing high-quality products Pipeline includes several commercial products in ophthalmology and transplant Also has a development stage pipeline in neurology What�
Wall Street brushes off initial worries over potential capital gains tax hike
12:20pm, Friday, 23'rd Apr 2021
12:15pm: Goldman, Apple among the day's leaders The Dow shook off a slow start and lingering pessimism around a potential capital gains tax increase out of the White House to climb 188 points, 0.6%,
Aequus sees fiscal 2020 revenue rise by 59%, driven by strong sales of Vistitan and Tacrolimus
08:18am, Friday, 23'rd Apr 2021
Aequus Pharmaceuticals Inc. (CVE:AQS) (OTCQB:AQSZF) (FRA:AEQ) posted fiscal 2020 results that saw its annual revenue jump 59% year-over-year on the back of strong sales led by PRVistitan and Tacrolimu
Aequus Provides General Update and Reports Record 2020 Financial Results
05:00am, Friday, 23'rd Apr 2021
VANCOUVER, British Columbia, April 23, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a fo
Aequus Pharmaceuticals: New Products To Accelerate Growth In 2021
02:58am, Wednesday, 07'th Apr 2021
Since my last article on 24 Jul 2020, the share price went up +158% and new products are expected to accelerate revenue growth in 2021. The annual financial report for 2020 is due end of April and, de
Aequus Pharmaceuticals receives $1.48 million from warrant acceleration exercises
01:58pm, Tuesday, 06'th Apr 2021
Aequus Pharmaceuticals Inc. (CVE:AQS) said that further to its announcement of March 2, 2021, shareholders have exercised approximately 79% of the available common share purchase warrants of the comp
Aequus Announces Notice of Warrant Acceleration
09:57pm, Tuesday, 02'nd Mar 2021
NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES
Aequus Pharmaceuticals bringing diverse pipeline of new drugs to the Canadian market
12:51pm, Monday, 01'st Mar 2021
Focused on developing and commercializing high-quality products Pipeline includes several commercial products in ophthalmology and transplant Also has a development stage pipeline in neurology What�
Aequus Pharmaceuticals closes non-brokered private placement with Marc Lustig for aggregate gross proceeds of $1,000,000
10:06am, Monday, 01'st Mar 2021
Aequus Pharmaceuticals Inc. (CVE:AQS) said it has closed a non-brokered private placement of 6,666,666 units of the company at a price of $0.15 each, for aggregate gross proceeds of $1,000,000 with
Aequus Pharmaceuticals announces the commercial availability of Evolve preservative-free lubricating eye drops for dry eye care
09:26am, Monday, 01'st Mar 2021
Aequus Pharmaceuticals Inc. (CVE:AQS) (OTCQB:AQSZF) has announced the commercial availability of Evolve preservative-free lubricating eye drops for dry eye care. The Canadian specialty pharmaceutical
Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada
08:00am, Monday, 01'st Mar 2021
VANCOUVER, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a Canadian specialty pharmaceutical company
Aequus Closes $1 Million Financing
08:45pm, Friday, 26'th Feb 2021
NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES
